Page last updated: 2024-08-25

tetrandrine and Heart Failure

tetrandrine has been researched along with Heart Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bian, ZY; Li, H; Liu, C; Shen, DF; Tang, QZ; Wang, L; Yan, L; Zhang, Y; Zhu, LH	1

Other Studies

1 other study(ies) available for tetrandrine and Heart Failure

Article	Year
Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling. British journal of pharmacology, 2010, Volume: 159, Issue:4 Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzylisoquinolines; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Fibrosis; Heart Failure; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; NFATC Transcription Factors; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recovery of Function; Signal Transduction; Time Factors; Transfection; Ultrasonography; Ventricular Function, Left	2010

Article

Year

Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.

British journal of pharmacology, 2010, Volume: 159, Issue:4

Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzylisoquinolines; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Fibrosis; Heart Failure; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; NFATC Transcription Factors; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recovery of Function; Signal Transduction; Time Factors; Transfection; Ultrasonography; Ventricular Function, Left

2010